ArticleTransboundary and emerging diseases2020
Novel coronavirus 2019, an emerging public health emergency.
Article in Transboundary and emerging diseases, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed, 1 synthesis or guideline pooled it.
- The effect of age on the incidence of COVID-19 complications: a systematic review and meta-analysis.Systematic reviews · 2021Pooled it
- Immunoglobulin G N-glycosylation remodeling in viral infections: immunomodulatory roles and potential biomarker implications.Frontiers in immunology · 2026Review
- Committed care in the shadow of fear: The experiences of emergency medical services staff encountering with COVID-19 patients.Journal of education and health promotion · 2025Article
- Synthesis and characterization of a nano-formulation for long lasting sterilization effect.Materials today. Proceedings · 2023Article
- Development and preliminary validation of a public health emergency competency model for medical staffs of national health emergency teams in China.BMC health services research · 2022Article
- Article
- Statistical Analysis and Machine Learning Prediction of Disease Outcomes for COVID-19 and Pneumonia Patients.Frontiers in cellular and infection microbiology · 2022Article
- SARS-CoV-2 Serological Survey of Cats in China before and after the Pandemic.Virologica Sinica · 2020Article
- Cats under the shadow of the SARS-CoV-2 pandemic.Transboundary and emerging diseases · 2020Article
- Serological survey of SARS-CoV-2 for experimental, domestic, companion and wild animals excludes intermediate hosts of 35 different species of animals.Transboundary and emerging diseases · 2020Article
- SARS-CoV-2, where to now?Transboundary and emerging diseases · 2020Article
Corrections and comments
- Comment on
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.